“Some patients with rare primary immunodeficiency disorders may be at risk for infection by rubella virus, and possibly serious skin inflammation, after receiving the rubella vaccine, usually administered as part of the measles-mumps-rubella (MMR) vaccine.”
Ludmila Perelygina, Stanley Plotkin, Pierre Russo, Timo Hautala, Francisco Bonilla, Hans D. Ochs, Avni Joshi, John Routes, Kiran Patel, Claudia Wehr, Joseph Icenogle, Kathleen E. Sullivan. Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. Journal of Allergy and Clinical Immunology, 2016; 138 (5): 1436 DOI: 10.1016/j.jaci.2016.06.030
